NEW JOURNAL STUDIES

Study affirms the systemic safety of anti-VEGF treatments
This retrospective study explored the safety of intravitreal anti-VEGF therapy in routine clinical practice. The authors examined records from 23,348 patients with diabetic macular edema (DME), including 13,365 treated with macular laser, 9,219 with intravitreal anti-VEGF and 764 with intravitreal corticosteroid. The analysis revealed a similar risk of cerebrovascular disease, major bleeding, myocardial infarction and serious adverse events among all 3 groups. Anti-VEGF injections, however, were tied to a higher risk of all-cause hospitalization compared with laser therapy (HR 1.17; P=0.01). The authors conclude anti-VEGF therapy for DME is relatively safe. Ophthalmology, July 2019

They might even provide a consultancy service, which means that they will be able to help you

There are two general kinds of essay: people composed to convey information or knowledge and those composed to express

Do you affordable-papers.net know that there are several types of newspapers available online and in books? There are various services that will aid you with this process.

opinion.

begin your own projects.

Leave a Comment

Your email address will not be published. Required fields are marked *